openPR Logo
Press release

Molecular Diagnostics Market to Reach USD 80.45 Billion by 2026 | TechSci Research

09-09-2021 08:30 AM CET | Health & Medicine

Press release from: TechSci Research LLC

Molecular Diagnostics Market - TechSci Research

Molecular Diagnostics Market - TechSci Research

Rising extensive research for better healthcare is driving the growth of global molecular diagnostics market in the forecast period, 2022-2026.

According to TechSci Research report, “Global Molecular Diagnostics Market By Products and Services (Reagents and Kits, Instruments, Services and Software), By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others), By Application (Infectious disease, Oncology testing, Genetic testing, Blood screening, Others), By End User (Hospitals, Academic & Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026”, the global molecular diagnostics market is projected to reach USD80.45 billion by 2026, owing to increasing geriatric population and rising cases of infectious diseases including COVID-19.

Furthermore, geriatric population is more prone to get infected with chronic and target diseases like cancer, lung diseases, Parkinson’s disease, heart diseases, diabetes, and require molecular diagnostics that would drive the market growth in the upcoming five years. Diseases like cancer, viral infections, neurological diseases including Alzheimer’s and Dementia are very risk prone for the old age patients. All these factors together with rising COVID-19 cases are anticipated to support the growth of the global molecular diagnostic market in the next five years. Moreover, rising cases of COVID-19 during 2020 and 2021 have raised the demand for RT-PCR testing which is likely to have a positive influence towards the growth of the market.

A collection of techniques that are used to analyze the biological markers in genome and proteome, and to understand the cells expressions as proteins while applying molecular biology to medical testing. Molecular diagnostics have widespread applications in neurological disorders, neuro degenerative diseases like Alzheimer’s, Parkinson’s, dementia, brain tumors, chronic depression, and more due to early and effective diagnosis.

Browse over 138 market data Figures spread through 110 Pages and an in-depth TOC on “Global Molecular Diagnostics Market"
https://www.techsciresearch.com/report/molecular-diagnostics-market/7463.html

The global molecular diagnostics market is segmented into products and services, technology, application, end user, regional distribution, and competitional landscape. Based on products and services, the market is further bifurcated into reagents and kits, instruments, services and software. Reagents and kits are anticipated to hold the largest share of the market in the next five years on account of their requirement for the purpose of research and development. Procedures like extraction of the genetic material, amplification of the genetic material, and separation of the proteins and other biomolecules require reagents and kits that can aid the research of the respective procedures. Moreover, in recent cases of COVID-19, the procedure of RT-PCR is prevailing for the diagnostic purposes of the viral infection in the patients. Reagents and kits were in demand for the large-scale diagnosis that is still prevailing in various countries like India, China, etc.

Based on application, the market is further fragmented into Infectious disease, Oncology testing, Genetic testing, Blood screening and Others. Infectious diseases are anticipated to hold the largest revenue shares in the upcoming five years on the grounds of increased prevalence of the COVID-19 across the globe. The pandemic has taken a toll on the world economy although, healthcare industry has experienced a surge in the demand for all sorts of healthcare products, services, testing kits, diagnostic instruments and equipment as well as the demand for effective treatment plans for the infected patients.

Major companies operating in the global molecular diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories Ltd., Danaher Corporation, Siemens Healthineers AG, Hologic Inc. (Gen Probe), Illumina Inc., Grifols S.A., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Becton, Dickinson and Company Ltd., Myriad Genetics Inc., Johnson & Johnson Services, Inc., bioMérieux SA, among others.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7463
Customers can also request for 10% free customization on this report.

“North America is anticipated to hold the largest share of the global market in the next five years on the account of government and private funding for R&D in molecular diagnostics, the increasing number of healthcare providers, geriatric population and rising incidence of chronic diseases. Also, the increased number of diseases is expected to drive the market players to operate in the region. New market players can strategize for significant market players by investing in the research and development of the technologically advanced products,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Molecular Diagnostics Market By Products and Services (Reagents and Kits, Instruments, Services and Software), By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others), By Application (Infectious disease, Oncology testing, Genetic testing, Blood screening, Others), By End User (Hospitals, Academic & Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of the global molecular diagnostics and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in the global molecular diagnostics market.

Browse Related Reports:
Global Cancer Biopsy Market By Product (Instruments, Kits and Consumables, Services), By Type of Biopsy (Tissue Biopsies (Needle and Surgical Biopsies), Liquid Biopsies, Others), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Others), By End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers), By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/cancer-biopsy-market/7399.html

Global Liver Cancer Therapeutics Market By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Liver Metastasis, Hepatoblastoma, Angiosarcoma), By Therapy (Targeted Therapy, Radiation and Chemotherapy Therapy, Immunotherapy, Others), By Equipment (Computed Radiography, MRI, Sonography, Others), By Age (0-18, 18-35, 35-50, 50+), By Factors (Non-Alcoholic Fatty Liver Disease, Cirrhosis, Excessive Liver Consumption, Others), By Route of Administration (Oral, Intra-Venous, Others ), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/liver-cancer-therapeutics-market/4667.html

Global Oncology Drugs Market By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent), By Route of Administration (Oral, Intravenous, Subcutaneous, Others), By Gender (Male, Female), By Cancer Type (Lung Cancer, Stomach Cancer, Others), By Distribution Channel (Hospital Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/oncology-drugs-market/4689.html

About TechSci Research:
TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Molecular Diagnostics Market to Reach USD 80.45 Billion by 2026 | TechSci Research here

News-ID: 2387054 • Views: 305

More Releases from TechSci Research LLC

Germany Medical Devices Market to Grow Due to Technological Advancement until 20 …
Technological advancement is driving the growth of Germany Medical Devices Market, in the forecast period, 2022-2026. According to TechSci report on, “Germany Medical Devices Market By Type (Cardiovascular Devices, Diagnostic Imaging Equipment, In-vitro Diagnostic Devices, Ophthalmic Devices, Diabetes Care Devices, Dental Care Devices, Surgical Equipment, Patient Monitoring Devices, Orthopedic Devices, Nephrology & Urology Devices, ENT Devices, Anesthesia & Respiratory Devices, Neurology Devices, Mobility-Aid Devices, Others), By End User (Hospitals & Clinics,
Japan Pharmaceuticals Market to Establish Growth with an Impressive CAGR Until F …
Enhancing pharmaceutical sector in the country is driving the growth if Japan Pharmaceuticals Market, FY2017-FY2027. According to TechSci report on, “Japan Pharmaceuticals Market By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, FY2027”, Japan pharmaceuticals market has shown promising growth in
Japan Generic Drugs Market to Establish Growth with an Impressive CAGR Until FY2 …
Enhancing pharmaceutical sector in the country is driving the growth if Japan Generic drugs Market, FY2017-FY2027. According to TechSci report on, “Japan Generic Drugs Market By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Application (Cardiovascular Diseases, Diabetes, Neurology,
Japan Medical Devices Market to Establish Growth with an Impressive CAGR Until F …
Increased advancement in the healthcare devices is driving the growth if Japan Medical Devices Market, FY2017-FY2027. According to TechSci report on, “Japan Medical Devices Market By Type (Cardiovascular Devices, Diagnostic Imaging Equipment, In-vitro Diagnostic Devices, Ophthalmic Devices, Diabetes Care Devices, Dental Care Devices, Surgical Equipment, Patient Monitoring Devices, Orthopedic Devices, Nephrology & Urology Devices, ENT Devices, Anesthesia & Respiratory Devices, Neurology Devices, Mobility-Aid Devices, Others), By End User (Hospitals & Clinics,

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and